End Of An Era? AstraZeneca Closes India Research Site Focused On Tropical Diseases
This article was originally published in PharmAsia News
Executive Summary
Stakeholders are asking if AstraZeneca remains committed to neglected tropical diseases after the company announces it will close its Indian research unit. The center was the last remaining big pharma basic research center in India.